The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 1×
“Interestingly, our intestinal microbiota is resistant to the sustained colonisation by exogenous bacteria (including the MDR ones), which is referred to as colonisation resistance (CR) [36, 37].”
BackgroundPrecision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Lowy, I., Molrine, D. C., Leav, B. A., Blair, B. M., Baxter, R., Gerding, D. N., Nichol, G., Thomas, W. D., Leney, M., Sloan, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907635 · Cited by 746
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
MALDI-TOF MS for the Diagnosis of Infectious Diseases
Patel, R. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.221770 · Cited by 534
Sarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., Bourdin, G., McCallin, S., Ngom-Bru, C., Neville, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.023 · Cited by 533
Mechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“CR is mainly exerted by anaerobes [38], yet the precise bacterial species underlying CR are still to be identified [39].”
BackgroundKaranika, S., Karantanos, T., Arvanitis, M., Grigoras, C., & Mylonakis, E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw283 · Cited by 453
Khanna, S., Pardi, D. S., Kelly, C. R., Kraft, C. S., Dhere, T., Henn, M. R., Lombardo, M.-J., Vulic, M., Ohsumi, T., Winkler, J., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv766 · Cited by 321
Antimicrobial Resistance Determinants and Future Control
Harbarth, S., & Samore, M. H. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1106.050167 · Cited by 315
Ruppé, E., Armand-Lefèvre, L., Estellat, C., Consigny, P.-H., El Mniai, A., Boussadia, Y., Goujon, C., Ralaimazava, P., Campa, P., Girard, P.-M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ333 · Cited by 278
Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs
Bauer, K. A., Perez, K. K., Forrest, G. N., & Goff, D. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu547 · Cited by 250
Salimnia, H., Fairfax, M. R., Lephart, P. R., Schreckenberger, P., DesJarlais, S. M., Johnson, J. K., Robinson, G., Carroll, K. C., Greer, A., Morgan, M., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01679-15 · Cited by 243
Phage therapy gets revitalized
Reardon, S. (2014) · Nature · doi:10.1038/510015a · Cited by 241
Bar-Yoseph, H., Hussein, K., Braun, E., & Paul, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw221 · Cited by 192
The Electronic Nose in Respiratory Medicine
Montuschi, P., Mores, N., Trové, A., Mondino, C., & Barnes, P. J. (2013) · Respiration · doi:10.1159/000340044 · Cited by 188
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria
Bassetti, M., De Waele, J. J., Eggimann, P., Garnacho-Montero, J., Kahlmeter, G., Menichetti, F., Nicolau, D. P., Paiva, J. A., Tumbarello, M., Welte, T., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3719-z · Cited by 181
Self-citationHua, L., Hilliard, J. J., Shi, Y., Tkaczyk, C., Cheng, L. I., Yu, X., Datta, V., Ren, S., Feng, H., Zinsou, R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02190-13 · Cited by 181
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams
Weiss, E., Zahar, J.-R., Lesprit, P., Ruppe, E., Leone, M., Chastre, J., Lucet, J.-C., Paugam-Burtz, C., Brun-Buisson, C., Timsit, J.-F., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.013 · Cited by 180
Self-citationCywes-Bentley, C., Skurnik, D., Zaidi, T., Roux, D., DeOliveira, R. B., Garrett, W. S., Lu, X., O’Malley, J., Kinzel, K., Zaidi, T., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303573110 · Cited by 177
Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
Köhler, T., Perron, G. G., Buckling, A., & van Delden, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000883 · Cited by 171
Ruppé, É., Lixandru, B. E., Cojocaru, R., Büke, Ç., Paramythiotou, E., Angebault, C., Visseaux, C., Djuikoue, C. I., Erdem, E., Burduniuc, O., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-13 · Cited by 150
MALDI‐TOF MS: an upcoming tool for rapid detection of antibiotic resistance in microorganisms
Kostrzewa, M., Sparbier, K., Maier, T. H. P., & Schubert, S. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300042 · Cited by 141
Teerawattanapong, N., Kengkla, K., Dilokthornsakul, P., Saokaew, S., Apisarnthanarak, A., & Chaiyakunapruk, N. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix112 · Cited by 140
Cambray, G., Sanchez-Alberola, N., Campoy, S., Guérin, É., Re, S. D., González‐Zorn, B., Ploy, M.-C., Barbé, J., Mazel, D., & Erill, I. (2011) · Mobile DNA · doi:10.1186/1759-8753-2-6 · Cited by 136
van Delden, C., Köhler, T., Brunner‐Ferber, F., François, B., Carlet, J. M., & Pechère, J.-C. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2559-3 · Cited by 122
Crowther, G. S., Baines, S. D., Todhunter, S. L., Freeman, J., Chilton, C. H., & Wilcox, M. H. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks359 · Cited by 120
Warrener, P., Varkey, R., Bonnell, J. C., DiGiandomenico, A., Camara, M., Cook, K. E., Li, P., Zha, J., Chowdury, P., Sellman, B. R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02643-14 · Cited by 119
Manges, A. R., Steiner, T. S., & Wright, A. J. (2016) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2016.1177199 · Cited by 119
Grundmann, H., Schouls, L. M., Aanensen, D. M., Pluister, G. N., Tami, A., Chlebowicz, M. A., Glasner, C., Sabat, A., Weist, K., Heuer, O. E., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.49.20987 · Cited by 116
Hockstein, N. G., Thaler, E. R., Torigian, D. A., Miller, W. T., Deffenderfer, O., & Hanson, C. W. (2004) · The Laryngoscope · doi:10.1097/00005537-200410000-00005 · Cited by 108
Electronic Nose Prediction of a Clinical Pneumonia Score: Biosensors and Microbes
Hanson, C. W., & Thaler, E. R. (2004) · Anesthesiology · doi:10.1097/00000542-200501000-00013 · Cited by 104
Jun, S. Y., Jung, G. M., Yoon, S. J., Choi, Y., Koh, W. S., Moon, K., & Kang, S. H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02232-13 · Cited by 102
Brink, A. J., Messina, A. P., Feldman, C. H., Richards, G. A., van den Bergh, D., & on behalf of the Netcare Antimicrobial Stewardship Study Alliance (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw523 · Cited by 98
Self-citationAntibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1
Jun, S. Y., Jung, G. M., Yoon, S. J., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.011 · Cited by 97
European Regulatory Conundrum of Phage Therapy
Verbeken, G., Vos, D. D., Vaneechoutte, M., Merabishvili, M., Zizi, M., & Pirnay, J. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.485 · Cited by 94
Bassetti, M., Carnelutti, A., & Peghin, M. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1251840 · Cited by 93
Self-citationElectronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia
Schnabel, R. M., Boumans, M.-L. L., Smolinska, A., Stobberingh, E. E., Kaufmann, R., Roekaerts, P. M. H. J., & Bergmans, D. C. J. J. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.09.014 · Cited by 88
Kanamori, H., Parobek, C. M., Juliano, J. J., van Duin, D., Cairns, B. A., Weber, D. J., & Rutala, W. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-16 · Cited by 83
de Gunzburg, J., Ducher, A., Modeß, C., Wegner, D., Oswald, S., Dressman, J., Augustin, V., Féger, C., Andremont, A., Weitschies, W., et al. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.359 · Cited by 76
Bhalla, A., Pultz, N. J., Ray, A. J., Hoyen, C. K., Eckstein, E. C., & Donskey, C. J. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502267 · Cited by 75
Biliński, J., Grzesiowski, P., Muszyński, J., Wróblewska, M., Mądry, K., Robak, K., Dzieciątkowski, T., Wiktor-Jędrzejczak, W., & Basak, G. W. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0387-9 · Cited by 75
Skurnik, D., Cywes‐Bentley, C., & Pier, G. B. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1159135 · Cited by 69
Kaleko, M., Bristol, J. A., Hubert, S., Parsley, T. B., Widmer, G., Tzipori, S. R., Subramanian, P., Hasan, N. A., Koski, P., Kokai‐Kun, J. F., et al. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.015 · Cited by 69
van Bunnik, B. A. D., & Woolhouse, M. E. J. (2017) · Royal Society Open Science · doi:10.1098/rsos.161067 · Cited by 67
Lee, B. Y., Bartsch, S. M., Wong, K. F., McKinnell, J. A., Slayton, R. B., Miller, L. G., Cao, C., Kim, D. S., Kallen, A. J., Jernigan, J. A., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv299 · Cited by 64
Individualized Approaches Are Needed for Optimized Blood Cultures
Banerjee, R., Özenci, V., & Patel, R. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw573 · Cited by 62
Gosalbes, M. J., Vázquez-Castellanos, J. F., Angebault, C., Woerther, P., Ruppé, É., Ferrús, M. L., Latorre, A., Andremont, A., & Moyá, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01528-15 · Cited by 46
Gaibani, P., Galea, A., Fagioni, M., Ambretti, S., Sambri, V., & Landini, M. P. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01242-16 · Cited by 44
Léone, M., Malavieille, F., Papazian, L., Meyssignac, B., Cassir, N., Textoris, J., Antonini, F., Scola, B. L., Martin, C., Allaouchiche, B., et al. (2013) · Critical Care · doi:10.1186/cc12849 · Cited by 36
Mellata, M., Mitchell, N. M., Schödel, F. P., Curtiss, R., & Pier, G. B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.12.014 · Cited by 36
The EVAMICA study team, Cambau, E., Durand‐Zaleski, I., Bretagne, S., Brun‐Buisson, C., Cordonnier, C., Duval, X., Herwegh, S., Pottecher, J., Courcol, R., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4766-4 · Cited by 33
Grall, N., Massias, L., Nguyen, T. T., Sayah‐Jeanne, S., Ducrot, N., Chachaty, É., de Gunzburg, J., & Andremont, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-13 · Cited by 32
Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae
Skurnik, D., Roux, D., Pons, S., Guillard, T., Lü, X., Cywes‐Bentley, C., & Pier, G. B. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv448 · Cited by 31
Bernard, J., Armand-Lefèvre, L., Luce, E., Mniai, A. E., Chau, F., Casalino, E., Andremont, A., & Ruppé, É. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.015 · Cited by 27
Antibiotic Susceptibility Testing
Arena, F., Viaggi, B., Galli, L., & Rossolini, G. M. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000844 · Cited by 27
Newitt, S., Myles, P. R., Birkin, J., Maskell, V., Slack, R., Nguyen‐Van‐Tam, J. S., & Szatkowski, L. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.12.016 · Cited by 21
Watkins, R., Smith, T. C., & Bonomo, R. A. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1216314 · Cited by 19
Woerther, P., Micol, J., Angebault, C., Pasquier, F., Pilorge, S., Bourhis, J.-H., de Botton, S., Gachot, B., & Chachaty, É. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000078 · Cited by 17
Dureau, A., Duclos, G., Antonini, F., Boumaza, D., Cassir, N., Alingrin, J., Vigne, C., Hammad, E., Zieleskiewicz, L., & Léone, M. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2795-5 · Cited by 13
Cited by
Wunderink, R. G., Giamarellos-Bourboulis, E. J., Rahav, G., Mathers, A. J., Bassetti, M., Vazquez, J., Cornely, O. A., Solomkin, J., Bhowmick, T., Bishara, J., et al. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0214-1 · Cited by 461
Self-citationBloodstream infections in critically ill patients: an expert statement
Timsit, J.-F., Ruppé, E., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 448
Self-citationBacteriophage Therapy: Clinical Trials and Regulatory Hurdles
Furfaro, L. L., Payne, M. S., & Chang, B. J. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00376 · Cited by 362
Electronic Nose and Its Applications: A Survey
Karakaya, D., Ulucan, O., & Turkan, M. (2020) · International Journal of Automation and Computing · doi:10.1007/s11633-019-1212-9 · Cited by 353
Kollef, M. H., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Shime, N., Martin-Loeches, I., Timsit, J.-F., Wunderink, R. G., Bruno, C. J., Huntington, J. A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30403-7 · Cited by 345
Metadata
- Authors
- Bassetti, M., Poulakou, G., Ruppe, E., Bouza, E., Van Hal, S. J., & Brink, A.
- Venue
- Intensive Care Medicine
- Published
- 2017-07-21
- Volume
- 43
- Issue
- 10
- Pages
- 1464-1475
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2737095712
- Cited by
- 277
- References
- 67
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.